WIBOFA - Validation of SCT02 With ECG-App for Detection of AF - Trial NCT06351761
Access comprehensive clinical trial information for NCT06351761 through Pure Global AI's free database. This phase not specified trial is sponsored by Withings and is currently Not yet recruiting. The study focuses on Atrial Fibrillation. Target enrollment is 270 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Investigational Device (Withings SCT02) 30 second Electrocardiogram recording
Interventional
device
Sponsor & Location
Withings
Timeline & Enrollment
N/A
May 01, 2024
Mar 01, 2025
Primary Outcome
Co-primary outcome 1 - Sensitivity of Investigational Device,Co-primary outcome 2 - Specificity of Investigational Device
Summary
The aim of the study is to evaluate the performance of Withings SCT02 with embedded Withings
 ECG-app in the automatic detection of atrial fibrillation
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06351761
Device Trial